Reuters logo
BRIEF-Aimmune Therapeutics Q4 loss per share $0.55
March 15, 2017 / 11:28 AM / 6 months ago

BRIEF-Aimmune Therapeutics Q4 loss per share $0.55

March 15 (Reuters) - Aimmune Therapeutics Inc

* Aimmune Therapeutics announces fourth quarter and full year 2016 financial results

* Sees 2017 capital expenditures approximately $5 million

* Qtrly loss per share $0.55

* Sees 2017 research and development expenses $95 million - $105 million

* Q4 earnings per share view $-0.47 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below